Regulated information

Transgene announces the success of its capital increase.

Learn more about the details of the operation.

The following pages contain information regarding the rights offering of Transgene. For regulatory reasons, the distribution of the content of this site is restricted. Consequently, please fill out the fields below to access the following pages.

➜ Learn More

Monthly information on shares outstanding and voting rights (in French)

Liquidity contract related information